Cargando…
Nasal Nitric Oxide Levels: Improving the Diagnosis of Primary Ciliary Dyskinesia in Puerto Rico
HIGHLIGHTS: What are the main findings? Patients with the RSPH4A (c.921+3_921+6del (intronic)) founder mutation have low nNO levels. Adding new diagnostic tools such as nNO levels improved the diagnosis of PCD in Puerto Rico. What is the implication of the main finding? Levels of nNO should be measu...
Autores principales: | De Jesús-Rojas, Wilfredo, Alvarado-Huerta, Francisco, Meléndez-Montañez, Jesús M., Muñiz-Hernández, José, Santos-López, Arnaldo, Mosquera, Ricardo A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717333/ https://www.ncbi.nlm.nih.gov/pubmed/36285978 http://dx.doi.org/10.3390/arm90050050 |
Ejemplares similares
-
The Genetics of Primary Ciliary Dyskinesia in Puerto Rico
por: De Jesús-Rojas, Wilfredo, et al.
Publicado: (2022) -
77680 Nasal Nitric Oxide Levels as a Diagnostic Tool for Primary Ciliary Dyskinesia in Puerto Rico
por: De Jesus Rojas, Wilfredo, et al.
Publicado: (2021) -
The RSPH4A Gene in Primary Ciliary Dyskinesia
por: De Jesús-Rojas, Wilfredo, et al.
Publicado: (2023) -
Primary Ciliary Dyskinesia: Ancestral Haplotypes Analysis of the RSPH4A Founder Mutation in Puerto Rico
por: De Jesús-Rojas, Wilfredo, et al.
Publicado: (2021) -
Primary Ciliary Dyskinesia Diagnostic Challenges: Understanding the Clinical Phenotype of the Puerto Rican RSPH4A Founder Mutation
por: De Jesús-Rojas, Wilfredo, et al.
Publicado: (2021)